Hurley LH - Search Results

1

Telomere maintenance mechanisms as a target for drug development.

Bearss DJ, Hurley LH, Von Hoff DD. Bearss DJ, et al. Among authors: hurley lh. Oncogene. 2000 Dec 27;19(56):6632-41. doi: 10.1038/sj.onc.1204092. Oncogene. 2000. PMID: 11426649 Review.

2

Telomeres and telomerases as drug targets.

Rezler EM, Bearss DJ, Hurley LH. Rezler EM, et al. Among authors: hurley lh. Curr Opin Pharmacol. 2002 Aug;2(4):415-23. doi: 10.1016/s1471-4892(02)00182-0. Curr Opin Pharmacol. 2002. PMID: 12127874 Review.

3

Telomere inhibition and telomere disruption as processes for drug targeting.

Rezler EM, Bearss DJ, Hurley LH. Rezler EM, et al. Among authors: hurley lh. Annu Rev Pharmacol Toxicol. 2003;43:359-79. doi: 10.1146/annurev.pharmtox.43.100901.135733. Epub 2002 Jan 10. Annu Rev Pharmacol Toxicol. 2003. PMID: 12540745 Review.

4

Identification of a lead small-molecule inhibitor of the Aurora kinases using a structure-assisted, fragment-based approach.

Warner SL, Bashyam S, Vankayalapati H, Bearss DJ, Han H, Mahadevan D, Von Hoff DD, Hurley LH. Warner SL, et al. Among authors: hurley lh. Mol Cancer Ther. 2006 Jul;5(7):1764-73. doi: 10.1158/1535-7163.MCT-05-0524. Mol Cancer Ther. 2006. PMID: 16891462

5

Comparing Aurora A and Aurora B as molecular targets for growth inhibition of pancreatic cancer cells.

Warner SL, Munoz RM, Stafford P, Koller E, Hurley LH, Von Hoff DD, Han H. Warner SL, et al. Among authors: hurley lh. Mol Cancer Ther. 2006 Oct;5(10):2450-8. doi: 10.1158/1535-7163.MCT-06-0202. Mol Cancer Ther. 2006. PMID: 17041088

6

The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo.

Grand CL, Han H, Muñoz RM, Weitman S, Von Hoff DD, Hurley LH, Bearss DJ. Grand CL, et al. Among authors: hurley lh. Mol Cancer Ther. 2002 Jun;1(8):565-73. Mol Cancer Ther. 2002. PMID: 12479216

7

Telomere-interactive agents affect proliferation rates and induce chromosomal destabilization in sea urchin embryos.

Izbicka E, Nishioka D, Marcell V, Raymond E, Davidson KK, Lawrence RA, Wheelhouse RT, Hurley LH, Wu RS, Von Hoff DD. Izbicka E, et al. Among authors: hurley lh. Anticancer Drug Des. 1999 Aug;14(4):355-65. Anticancer Drug Des. 1999. PMID: 10625928

8

Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.

Rha SY, Izbicka E, Lawrence R, Davidson K, Sun D, Moyer MP, Roodman GD, Hurley L, Von Hoff D. Rha SY, et al. Clin Cancer Res. 2000 Mar;6(3):987-93. Clin Cancer Res. 2000. PMID: 10741725

9

DNA G-quadruplexes, telomere-specific proteins and telomere-associated enzymes as potential targets for new anticancer drugs.

Raymond E, Soria JC, Izbicka E, Boussin F, Hurley L, Von Hoff DD. Raymond E, et al. Invest New Drugs. 2000 May;18(2):123-37. doi: 10.1023/a:1006373812586. Invest New Drugs. 2000. PMID: 10857992 Review.

10

Drug targeting of the c-MYC promoter to repress gene expression via a G-quadruplex silencer element.

Hurley LH, Von Hoff DD, Siddiqui-Jain A, Yang D. Hurley LH, et al. Semin Oncol. 2006 Aug;33(4):498-512. doi: 10.1053/j.seminoncol.2006.04.012. Semin Oncol. 2006. PMID: 16890804 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters